CRA International
Advises companies, law firms, and governments on disputes, regulation, and strategy.
Something off on this page? Send us feedback.
Profile
Provides economic, financial, litigation, regulatory, and management consulting under the Charles River Associates trade name. Work centers on specialist practices such as antitrust, energy, forensic services, life sciences, labor, investigations, transfer pricing, and Marakon strategy advice.
Provides consulting services rather than packaged products, with work organized into litigation, regulatory, and financial consulting and management consulting. Practice lines include antitrust and competition economics, energy, finance, forensic services, intellectual property, labor and employment, life sciences, Risk, Investigations & Analytics, Transfer Pricing, and Marakon.
Operates as a Boston-based public issuer under the Charles River Associates trade name, with one global professional-and-consulting-services segment. Client work spans companies, law firms, accounting firms, and governments that need economic, financial, strategic, or policy analysis.
Performance depends on senior expertise, utilization, and reputation in fragmented consulting markets with low barriers to entry. Revenue is tied largely to consultant hours, so hiring, retention, and the quality of expert work shape the business.
Company facts
Key statistics
Year to date −12.8% · Average volume (30d) 132.8K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026Q2 FY26 | $2.15 | $2.16 | +0.5% | $198.9M | $210.8M | +6.0% | −0.08% |
| May 7, 2026Q1 FY26 | $2.02 | $1.99 | −1.5% | $193.8M | $201.0M | +3.7% | +0.33% |
| Feb 26, 2026Q4 FY25 | $2.05 | $2.06 | +0.5% | $190.6M | $197.0M | +3.4% | +3.14% |
| Oct 30, 2025Q3 FY25 | $1.80 | $2.06 | +14.4% | $190.5M | $185.9M | −2.4% | +3.13% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $181.9M | $186.9M | $185.9M | $197.0M | $201.0M | $210.8M | |
| Gross profit | $61.5M | $58.3M | $50.9M | $47.4M | $52.6M | $210.8M | |
| Operating income | $25.5M | $19.7M | $17.2M | $20.6M | $18.0M | $23.5M | |
| Net income | $18.0M | $12.1M | $11.5M | $13.2M | $11.1M | $13.5M | |
| Diluted EPS | $2.62 | $1.79 | $1.73 | $1.99 | $1.69 | $2.10 | |
| Gross margin | 33.8% | 31.2% | 27.4% | 24.1% | 26.2% | 100.0% | |
| Operating margin | 14.0% | 10.6% | 9.3% | 10.5% | 9.0% | 11.2% |
Fiscal years (4-quarter sums)FY21 $565.9M · FY22 $590.9M · FY23 $624.0M · FY24 $687.4M · FY25 $751.6M
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jul 4, 2026Cash & short-term investments $18.2M · Total debt $194.2M · Total assets $665.3M · Shareholders' equity $182.7M
Dividends
Raised for 8 straight years — most recently to $0.57 from $0.49 in Nov 2025. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 25, 2026 | Aug 25 | Sep 14 | $0.57 | |
| May 26, 2026 | May 26 | Jun 12 | $0.57 | |
| Mar 10, 2026 | Mar 10 | Mar 20 | $0.57 | |
| Nov 25, 2025 | Nov 25 | Dec 12 | $0.57 | raised from $0.49 |
| Aug 26, 2025 | Aug 26 | Sep 12 | $0.49 | |
| May 27, 2025 | May 27 | Jun 13 | $0.49 | |
| Mar 4, 2025 | Mar 4 | Mar 14 | $0.49 | |
| Nov 26, 2024 | Nov 26 | Dec 13 | $0.49 | raised from $0.42 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 6.46M · Float 6.22M · 96.2% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 643.0K | 9.95% | 13F | Aug 7, 2026 |
| FMR LLC | 470.2K | 7.27% | 13F | Aug 13, 2026 |
| Vanguard Capital Management | 325.5K | 5.03% | 13G | Jul 31, 2026 |
| Two Sigma Investments, LP | 261.7K | 4.05% | 13F | Aug 14, 2026 |
| Needham Investment Management LLC | 215.5K | 3.33% | 13F | Aug 14, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 25, 2026 | Jonathan D. Yellin | officer: EVP AND GENERAL COUNSEL | −2,250 | $173.25 |
| Jul 23, 2026 | Heather Tookes | director | −88 | $165.90 |
| Jul 16, 2026 | Heather Tookes | director | −124 | $173.31 |
| Jun 3, 2026 | Paul A. Maleh | director, officer: PRESIDENT AND CEO | −7,500 | $136.83 |
| May 19, 2026 | Jonathan D. Yellin | officer: EVP AND GENERAL COUNSEL | −2,250 | $147.72 |
Peers
- FTI Consulting
Direct economics and disputes peer through Compass Lexecon and FLC
- Marsh McLennan
Economics and management consulting overlap via NERA and Oliver Wyman
- Huron Consulting Group
Industry-focused consulting pressure in healthcare, education, and commercial
- ICF
Policy, energy, health, and analytics advisory overlap
- Exponent
Scientific expert consulting peer in disputes and regulatory matters
- Accenture
Large-scale strategy and transformation consulting alternative
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| CRA International | $174.34 | −0.31% | $1.13B | 23.3 | 19.4 | 1.4 | +12.8% |
| FTI Consulting | $153.74 | −0.06% | $4.25B | 19.0 | 14.8 | 1.1 | +5.3% |
| Marsh McLennan | $185.69 | −3.61% | $91.93B | 23.6 | 17.6 | 3.3 | +6.2% |
| Huron Consulting Group | $159.84 | −0.04% | $2.54B | 23.9 | 16.7 | 1.4 | +15.7% |
| ICF | $90.22 | +0.03% | $1.63B | 18.7 | 12.1 | 0.9 | −0.4% |
| Exponent | $71.53 | −0.03% | $3.47B | 32.1 | 29.3 | 5.5 | +4.9% |
| Accenture | $189.20 | −0.17% | $116.03B | 15.1 | 13.2 | 1.6 | +5.6% |
| Median | 21.3 | 15.8 | 1.5 | +5.4% |